Anda di halaman 1dari 16

Renub Research

www.renub.com
Europe Cervical Cancer Test Market, Patients, By Screening Type (Pap
Smear, HPV DNA) (United Kingdom, France, Germany, Italy, Spain,
Sweden, Switzerland, Norway, Netherlands)

Published: January, 2017


Renub Research

Page 1 of 16

Copyright 2017 Renub Research All Rights Reserved

Cervical cancer is one of the most serious public health issues in Europe. Despite
introduction of vaccination in 21 European countries, still more than 24 Thousand women
have died from cervical cancer across all over Europe. Cervical cancer incidence rate in
Europe was 10.6 per 100,000 women population. Germany, France and United Kingdom are
top three dominating countries in the Europe cervical cancer market in 2015.
Europe Cervical Cancer Test Market, Patients, By Screening Type (Pap Smear, HPV DNA)
(United Kingdom, France, Germany, Italy, Spain, Sweden, Switzerland, Norway,
Netherlands) is 119 Page market research report with 115 Figures and 2 Tables published
by Renub Research. All the 9 countries in the report have been studied from 3 viewpoints.

Cervical Cancer Test Market, Population & Mortality


1. Cervical Cancer Test Population (2008-2020)

Pap Smear Test Population & Forecast

HPV DNA Test Population & Forecast

2. Cervical Cancer Mortality Population (2001-2011)


3. Cervical Cancer Test Market (2008-2020)

Pap Smear Test Market & Forecast

HPV DNA Test Market & Forecast

9 Countries studied in the report are as follows


1. United Kingdom

6. Sweden

2. France

7. Switzerland

3. Germany

8. Norway

4. Italy

9. Netherlands

5. Spain

Renub Research

Page 2 of 16

Data Sources
This report is built using data and information sourced from proprietary databases, primary
and secondary research and in-house analysis by Renub Research team of industry experts.
Primary sources include industry surveys and telephone interviews with industry experts.
Secondary sources information and data has been collected from various printable and nonprintable sources like search engines, News websites, Government Websites, Trade
Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations,
Books, Industry Portals, Industry Associations and access to more than 1000 paid databases.

Renub Research

Page 3 of 16

Table of Contents
1.

Executive Summary

2.

Europe Cervical Cancer Test (Screening) Population & Forecast

3.

Europe Cervical Cancer Test (Screening) Market & Forecast

4.

5.

3.1

Europe Cervical Cancer Pap Smear Test (Screening) Market & Forecast

3.2

Europe Cervical Cancer HPV DNA Test (Screening) Market & Forecast

Europe Cervical Cancer Test (Screening) Population Share, Market Share & Forecast
4.1

Europe Cervical Cancer Test (Screening) Population Share & Forecast

4.2

Europe Cervical Cancer Test (Screening) Market Share & Forecast

4.3

Europe Cervical Cancer Pap Smear Test (Screening) Market Share & Forecast

4.4

Europe Cervical Cancer HPV DNA Test (Screening) Market Share & Forecast

United Kingdom Cervical Cancer Test Analysis


5.1

6.

5.1.1

United Kingdom Cervical Cancer Pap Smear Test Population & Forecast

5.1.2

United Kingdom Cervical Cancer HPV DNA Test Population & Forecast

5.2

United Kingdom Cervical Cancer Deaths

5.3

United Kingdom Cervical Cancer Test (Screening) Analysis

5.3.1

United Kingdom Cervical Cancer Test Market & Forecast

5.3.2

United Kingdom Pap Smear Test Market & Forecast

5.3.3

United Kingdom HPV DNA Test Market & Forecast

France Cervical Cancer Test Analysis


6.1

7.

United Kingdom Cervical Cancer Test (Screening) Population

France Cervical Cancer Test (Screening) Population

6.1.1

France Cervical Cancer Pap Smear Test Population & Forecast

6.1.2

France Cervical Cancer HPV DNA Test Population & Forecast

6.2

France Cervical Cancer Mortality

6.3

France Cervical Cancer Test (Screening) Analysis

6.3.1

France Cervical Cancer Test Market & Forecast

6.3.2

France Pap Smear Test Market & Forecast

6.3.3

France HPV DNA Test Market & Forecast

Germany Cervical Cancer Test Analysis


7.1

Germany Cervical Cancer Test (Screening) Population

7.1.1

Germany Cervical Cancer Pap Smear Test Population & Forecast

Renub Research

Page 4 of 16

7.1.2

Germany Cervical Cancer HPV DNA Test Population & Forecast

7.2

Germany Cervical Cancer Mortality

7.3

Germany Cervical Cancer Test (Screening) Market

7.3.1

Germany Cervical Cancer Test Market & Forecast

7.3.2

Germany Pap Smear Test Market & Forecast

7.3.3

Germany HPV DNA Test Market & Forecast

Italy Cervical Cancer Test Analysis

8.

8.1

Italy Cervical Cancer Test (Screening) Population

8.1.1

Italy Cervical Cancer Pap Smear Test Population & Forecast

8.1.2

Italy Cervical Cancer HPV DNA Test Population & Forecast

8.2

Italy Cervical Cancer Mortality

8.3

Italy Cervical Cancer Test (Screening) Market

8.3.1

Italy Cervical Cancer Test Market & Forecast

8.3.2

Italy Pap Smear Test Market & Forecast

8.3.3

Italy HPV DNA Test Market & Forecast

Spain Cervical Cancer Test Analysis

9.

9.1

Spain Cervical Cancer Test (Screening) Population

9.1.1

Spain Cervical Cancer Pap Smear Test Population & Forecast

9.1.2

Spain Cervical Cancer HPV DNA Test Population & Forecast

9.2

Spain Cervical Cancer Mortality

9.3

Spain Cervical Cancer Test (Screening) Market

9.3.1

Spain Cervical Cancer Test Market & Forecast

9.3.2

Spain Pap Smear Test Market & Forecast

9.3.3

Spain HPV DNA Test Market & Forecast

Sweden Cervical Cancer Test Analysis

10.
10.1

Sweden Cervical Cancer Test (Screening) Population

10.1.1

Sweden Cervical Cancer Pap Smear Test Population & Forecast

10.1.2

Sweden Cervical Cancer HPV DNA Test Population & Forecast

10.2

Sweden Cervical Cancer Mortality

10.3

Sweden Cervical Cancer Test (Screening) Market

10.3.1

Sweden Cervical Cancer Test Market & Forecast

10.3.2

Sweden Pap Smear Test Market & Forecast

10.3.3

Sweden HPV DNA Test Market & Forecast

11.
11.1

Switzerland Cervical Cancer Test Analysis


Switzerland Cervical Cancer Test (Screening) Population

Renub Research

Page 5 of 16

11.1.1

Switzerland Cervical Cancer Pap Smear Test Population & Forecast

11.1.2

Switzerland Cervical Cancer HPV DNA Test Population & Forecast

11.2

Switzerland Cervical Cancer Mortality

11.3

Switzerland Cervical Cancer Test (Screening) Market

11.3.1

Switzerland Cervical Cancer Test Market & Forecast

11.3.2

Switzerland Pap smear Test Market & Forecast

11.3.3

Switzerland HPV DNA Test Market & Forecast

Norway Cervical Cancer Test Analysis

12.
12.1

Norway Cervical Cancer Test (Screening) Population

12.1.1

Norway Cervical Cancer Pap Smear Test Population & Forecast

12.1.2

Norway Cervical Cancer HPV DNA Test Population & Forecast

12.2

Norway Cervical Cancer Mortality

12.3

Norway Cervical Cancer Test (Screening) Market

12.3.1

Norway Cervical Cancer Test Market & Forecast

12.3.2

Norway Pap Smear Test Market & Forecast

12.3.3

Norway HPV DNA Test Market & Forecast

Netherlands Cervical Cancer Test Analysis

13.
13.1

Netherlands Cervical Cancer Test (Screening) Population

13.1.1

Netherlands Cervical Cancer Pap Smear Test Population & Forecast

13.1.2

Netherlands Cervical Cancer HPV DNA Test Population & Forecast

13.2

Netherlands Cervical Cancer Mortality

13.3

Netherlands Cervical Cancer Test (Screening) Market

13.3.1

Netherlands Cervical Cancer Test Market & Forecast

13.3.2

Netherlands Pap Smear Test Market & Forecast

13.3.3

Netherlands HPV DNA Test Market & Forecast

14.

Cervical Cancer Test Market Growth Drivers

14.1

Rising Cases of Teenage Sexual Cases Globally

14.2

Huge Prevalence of HPV Infected Patients Globally

15.
15.1

Challenges in Cervical Cancer Test Market


Introduction of HPV Vaccination Programs Globally

Renub Research

Page 6 of 16

List of Figures
Figure 2-1: Europe Cervical Cancer Test Population (Million), 2008 2015
Figure 2-2: Europe Forecast for Cervical Cancer Test Population (Million), 2016 2020
Figure 3-1: Europe Cervical Cancer Test Market (Million US$), 2008 2015
Figure 3-2: Europe Forecast for Cervical Cancer Test Market (Million US$), 2016 2020
Figure 3-3: Europe Cervical Cancer Pap Smear Test Market (Million US$), 2008 2015
Figure 3-4: Europe Forecast for Cervical Cancer Pap Smear Test Market (Million US$), 2016 2020
Figure 3-5: Europe Cervical Cancer HPV DNA Test Market (Million US$), 2008 2015
Figure 3-6: Europe Forecast for Cervical Cancer HPV DNA Test Market (Million US$), 2016 2020
Figure 4-1: Europe Cervical Cancer Test Population Share (Percent), 2008 2015
Figure 4-2: Europe Forecast for Cervical Cancer Test Population Share (Percent), 2016 2020
Figure 4-3: Europe Cervical Cancer Test Market Share (Percent), 2008 2015
Figure 4-4: Europe Forecast for Cervical Cancer Test Market Share (Percent), 2016 2020
Figure 4-5: Europe Cervical Cancer Pap Smear Test Market Share (Percent), 2008 2015
Figure 4-6: Europe Forecast for Cervical Cancer Pap Smear Test Market Share (Percent), 2016
2020
Figure 4-7: Europe Cervical Cancer HPV DNA Test Market Share (Percent), 2008 2015
Figure 4-8: Europe Forecast for Cervical Cancer HPV DNA Test Market Share (Percent), 2016
2020
Figure 5-1: United Kingdom Cervical Cancer Pap Smear Test Population (Thousand), 2008 2015
Figure 5-2: United Kingdom Forecast for Cervical Cancer Pap Smear Test Population (Thousand),
2016 2020
Figure 5-3: United Kingdom Cervical Cancer HPV DNA Test Population (Thousand), 2008 2015
Figure 5-4: United Kingdom Forecast for Cervical Cancer HPV DNA Test Population (Thousand),
2016 2020
Figure 5-5: United Kingdom Cervical Cancer Deaths (Number), 2001 2011
Figure 5-6: United Kingdom Cervical Cancer Test Market (Million US$), 2008 2015
Figure 5-7: United Kingdom Forecast for Cervical Cancer Test Market (Million US$), 2016 2020
Figure 5-8: United Kingdom Pap Smear Test Market (Million US$), 2008 2015
Figure 5-9: United Kingdom Forecast for Pap Smear Test Market (Million US$), 2016 2020
Figure 5-10: United Kingdom HPV DNA Test Market (Million US$), 2008 2015
Figure 5-11: United Kingdom Forecast for HPV DNA Test Market (Million US$), 2016 2020
Figure 6-1: France Cervical Cancer Pap Smear Test Population (Thousand), 2008 2015
Figure 6-2: France Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016
2020
Figure 6-3: France Cervical Cancer HPV DNA Test Population (Thousand), 2008 2015
Figure 6-4: France Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016 2020
Figure 6-5: France Cervical Cancer Mortality (Number), 2001 2011
Figure 6-6: France Cervical Cancer Test Market (Million US$), 2008 2015

Renub Research

Page 7 of 16

Figure 6-7: France Forecast for Cervical Cancer Test Market (Million US$), 2016 2020
Figure 6-8: France Pap Smear Test Market (Million US$), 2008 2015
Figure 6-9: France Forecast for Pap Smear Test Market (Million US$), 2016 2020
Figure 6-10: France HPV DNA Test Market (Million US$), 2008 2015
Figure 6-11: France Forecast for HPV DNA Test Market (Million US$), 2016 2020
Figure 7-1: Germany Cervical Cancer Pap Smear Test Population (Thousand), 2008 2015
Figure 7-2: Germany Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016
2020
Figure 7-3: Germany Cervical Cancer HPV DNA Test Population (Thousand), 2005 2013
Figure 7-4: Germany Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2014
2020
Figure 7-5: Germany Cervical Cancer Mortality (Number), 2001 2011
Figure 7-6: Germany Cervical Cancer Test Market (Million US$), 2008 2015
Figure 7-7: Germany Forecast for Cervical Cancer Test Market (Million US$), 2016 2020
Figure 7-8: Germany Pap Smear Test Market (Million US$), 2008 2015
Figure 7-9: Germany Forecast for Pap Smear Test Market (Million US$), 2016 2020
Figure 7-10: Germany HPV DNA Test Market (Million US$), 2008 2015
Figure 7-11: Germany Forecast for HPV DNA Test Market (Million US$), 2016 2020
Figure 8-1: Italy Cervical Cancer Pap Smear Test Population (Thousand), 2008 2015
Figure 8-2: Italy Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 2020
Figure 8-3: Italy Cervical Cancer HPV DNA Test Population (Thousand), 2008 2015
Figure 8-4: Italy Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016 2020
Figure 8-5: Italy Cervical Cancer Mortality (Number), 2001 2011
Figure 8-6: Italy Cervical Cancer Test Market (Million US$), 2008 2015
Figure 8-7: Italy Forecast for Cervical Cancer Test Market (Million US$), 2016 2020
Figure 8-8: Italy Pap Smear Test Market (Million US$), 2008 2015
Figure 8-9: Italy Forecast for Pap Smear Test Market (Million US$), 2016 2020
Figure 8-10: Italy HPV DNA Test Market (Million US$), 2008 2015
Figure 8-11: Italy Forecast for HPV DNA Test Market (Million US$), 2016 2020
Figure 9-1: Spain Cervical Cancer Pap Smear Test Population (Thousand), 2008 2015
Figure 9-2: Spain Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016 2020
Figure 9-3: Spain Cervical Cancer HPV DNA Test Population (Thousand), 2008 2015
Figure 9-4: Spain Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016 2020
Figure 9-5: Spain Cervical Cancer Mortality (Number), 2001 2011
Figure 9-6: Spain Cervical Cancer Test Market (Million US$), 2008 2015
Figure 9-7: Spain Forecast for Cervical Cancer Test Market (Million US$), 2016 2020
Figure 9-8: Spain Pap Smear Test Market (Million US$), 2008 2015
Figure 9-9: Spain Forecast for Pap Smear Test Market (Million US$), 2016 2020
Figure 9-10: Spain HPV DNA Test Market (Million US$), 2008 2015
Figure 9-11: Spain Forecast for HPV DNA Test Market (Million US$), 2016 2020

Renub Research

Page 8 of 16

Figure 10-1: Sweden Cervical Cancer Pap Smear Test Population (Thousand), 2008 2015
Figure 10-2: Sweden Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016
2020
Figure 10-3: Sweden Cervical Cancer HPV DNA Test Population (Thousand), 2008 2015
Figure 10-4: Sweden Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016
2020
Figure 10-5: Sweden Cervical Cancer Mortality (Number), 2001 2011
Figure 10-6: Sweden Cervical Cancer Test Market (Million US$), 2008 2015
Figure 10-7: Sweden Forecast for Cervical Cancer Test Market (Million US$), 2016 2020
Figure 10-8: Sweden Pap Smear Test Market (Million US$), 2008 2015
Figure 10-9: Sweden Forecast for Pap Smear Test Market (Million US$), 2016 2020
Figure 10-10: Sweden HPV DNA Test Market (Million US$), 2008 2015
Figure 10-11: Sweden Forecast for HPV DNA Test Market (Million US$), 2016 2020
Figure 11-1: Switzerland Cervical Cancer Pap Smear Test Population (Thousand), 2008 2015
Figure 11-2: Switzerland Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016
2020
Figure 11-3: Switzerland Cervical Cancer HPV DNA Test Population (Thousand), 2008 2015
Figure 11-4: Switzerland Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016
2020
Figure 11-5: Switzerland Cervical Cancer Mortality (Number), 2001 2011
Figure 11-6: Switzerland Cervical Cancer Test Market (Million US$), 2008 2015
Figure 11-7: Switzerland Forecast for Cervical Cancer Test Market (Million US$), 2016 2020
Figure 11-8: Switzerland Pap Smear Test Market (Million US$), 2008 2015
Figure 11-9: Switzerland Forecast for Pap Smear Test Market (Million US$), 2016 2020
Figure 11-10: Switzerland HPV DNA Test Market (Million US$), 2008 2015
Figure 11-11: Switzerland Forecast for HPV DNA Test Market (Million US$), 2016 2020
Figure 12-1: Norway Cervical Cancer Pap Smear Test Population (Thousand), 2008 2015
Figure 12-2: Norway Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016
2020
Figure 12-3: Norway Cervical Cancer HPV DNA Test Population (Thousand), 2008 2015
Figure 12-4: Norway Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016
2020
Figure 12-5: Norway Cervical Cancer Mortality (Number), 2001 2011
Figure 12-6: Norway Cervical Cancer Test Market (Million US$), 2008 2015
Figure 12-7: Norway Forecast for Cervical Cancer Test Market (Million US$), 2016 2020
Figure 12-8: Norway Pap Smear Test Market (Million US$), 2008 2015
Figure 12-9: Norway Forecast for Pap Smear Test Market (Million US$), 2016 2020
Figure 12-10: Norway HPV DNA Test Market (Million US$), 2008 2015
Figure 12-11: Norway Forecast for HPV DNA Test Market (Million US$), 2016 2020
Figure 13-1: Netherlands Cervical Cancer Pap Smear Test Population (Thousand), 2008 2015

Renub Research

Page 9 of 16

Figure 13-2: Netherlands Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2016
2020
Figure 13-3: Netherlands Cervical Cancer HPV DNA Test Population (Thousand), 2008 2015
Figure 13-4: Netherlands Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2016
2020
Figure 13-5: Netherlands Cervical Cancer Mortality (Number), 2001 2011
Figure 13-6: Netherlands Cervical Cancer Test Market (Million US$), 2008 2015
Figure 13-7: Netherlands Forecast for Cervical Cancer Test Market (Million US$), 2016 2020
Figure 13-8: Netherlands Pap Smear Test Market (Million US$), 2008 2015
Figure 13-9: Netherlands Forecast for Pap Smear Test Market (Million US$), 2016 2020
Figure 13-10: Netherlands HPV DNA Test Market (Million US$), 2008 2015
Figure 13-11: Netherlands Forecast for HPV DNA Test Market (Million US$), 2016 2020

Renub Research

Page 10 of 16

List of Tables
Table 25-3: Worldwide Prevalence (Percent) of Young Women (1544 Years) who Have Sex before
the Age of 15 Years, 1994 2006
Table 25-4: Worldwide HPV Prevalence (Percent) among Women with Normal Cervical Cytology,
2010

Renub Research

Page 11 of 16

About Us
Renub Research is a leading Market Research and Information Analysis Company with
centers at Noida India and Roswell USA. We have long-term experience especially in
international Business-to-Business Researches, Surveys, Business and Consulting. Throughout
the years we have acquired expertise in most market sectors, including Information
Technology (IT), Telecoms, Life Sciences, Medical & Pharmaceuticals, Financial Services
(Banking, Insurance, Reinsurance, M&A, etc.), Energy, Chemicals, Automotive, Retail,
FMCG, Consumer Goods, Logistics, Governmental, Social, and Others.
Our core team is comprised of an experienced people holding graduate, post graduate and
Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine,
Information Technology, Environmental Science and many more. Our research help make
the business decisions: on strategy, organization, operations, technology, mergers &
acquisitions etc. We support many blue chip companies by providing them findings and
perspectives across a wide range of markets. Our research reports offer a blend of
information insight, analysis and forecasting that is essential in todays ultra-competitive
markets.

For more information on us or to view any of our sample work you can
mail us at info@renub.com

Renub Research

Page 12 of 16

Published
By

Renub Research
1st Floor,
C-86, Sector10
Noida 201301
Phone: +91-120-421-9822 (India)
+1-678-302-0700 (USA)
Email: info@renub.com
www.renub.com

Europe Cervical Cancer Test Market, Patients, By Screening Type (Pap Smear, HPV
DNA) (United Kingdom, France, Germany, Italy, Spain, Sweden, Switzerland, Norway,
Netherlands)
Renub Research, 2016
Edition 1.0
All rights reserved. This publication is protected
by copyright. No part of it may be reproduced, stored
in a retrieval system or transmitted, in any form or by
any means, electronic mechanical, photocopying,
recording or otherwise without the prior written
permission of the publishers

Renub Research

Page 13 of 16

Order Form
Scan and e-mail this page to info@renub.com, alternatively one can also write the Contact
Information in an e-mail and mail it. Else you can also fax this form to +91-120-424-9780
Questions? Please call +91-120-421-9822 (India), +1-678-302-0700 (USA) or mail to
info@renub.com

Format

Report Title:
Europe Cervical Cancer Test Market, Patients, By Screening Type (Pap Smear, HPV DNA)
(United Kingdom, France, Germany, Italy, Spain, Sweden, Switzerland, Norway,
Netherlands)
Single User
(Email from Publisher)

Hard Copy
(Mail Delivery)

CD Rom
(Mail Delivery)

Global Site License


(Multiple User License)

US$ 1250

US$ 1350

US$ 1400

US$ 2050

For ordering this report: Easy ways to place your order:


1) Order online by Credit Card (Visa, MasterCard, etc.):
http://www.renub.com/europe-cervical-cancer-test-market-patients-by-screening-typepap-smear-hpv-dna-united-kingdom-france-germany-italy-spain-sweden-switzerlandnorway-netherlands-989-p.php

Renub Research

Page 14 of 16

Contact Information
First Name:

Last Name:

Email:
Job Title:
Company:
Address:
City:
Postal/Zip Code:
Country:
Phone:
Mobile:
Fax:
Report Format:
Your message:

3) Order by Check
Please post the check accompanied by this form, to:
Company Address: Renub Research
1st Floor
C-86, Sector -10
Noida - 201301
Uttar Pradesh
India
Phone: +91-120-421-9822, 424-9780

Renub Research

Page 15 of 16

For free Sample copy report or to view any of our sample work please contact us at
info@renub.com or call +91-120-421-9822 (India), +1-678-302-0700 (USA)

Follow Us
Facebook: https://www.facebook.com/RenubResearch
LinkedIn: https://www.linkedin.com/company/renub-research
Twitter:

https://twitter.com/renubresearch

Youtube:

https://www.youtube.com/c/renubresearch

Renub Research

Page 16 of 16